blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2981550

EP2981550 - ARTIFICIAL TRANSCRIPTION FACTORS FOR THE TREATMENT OF DISEASES CAUSED BY OPA1 HAPLOINSUFFICIENCY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.11.2016
Database last updated on 14.09.2024
Most recent event   Tooltip11.11.2016Change: Loss of particular rights: legal effect 
11.11.2016New entry: Loss of particular rights: legal effect 
11.11.2016Application deemed to be withdrawnpublished on 14.12.2016  [2016/50]
Applicant(s)For all designated states
Aliophtha AG
Elisabethenstrasse 43
4051 Basel / CH
[2016/06]
Inventor(s)01 / NEUTZNER, Albert
Schwarzwaldblick 7
79418 Schliengen / DE
02 / FLAMMER, Josef
Ob dem Hügliacker 76
4102 Binningen / CH
03 / HUXLEY, Alice
Huebweg 25
4102 Binningen / CH
 [2016/06]
Representative(s)Latscha Schöllhorn Partner AG
Austrasse 24
4051 Basel / CH
[2016/06]
Application number, filing date14718351.102.04.2014
[2016/06]
WO2014EP56590
Priority number, dateEP2013016218903.04.2013         Original published format: EP 13162189
[2016/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014161881
Date:09.10.2014
Language:EN
[2014/41]
Type: A1 Application with search report 
No.:EP2981550
Date:10.02.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2014 takes the place of the publication of the European patent application.
[2016/06]
Search report(s)International search report - published on:EP09.10.2014
ClassificationIPC:C07K14/47
[2016/06]
CPC:
C07K14/4702 (EP,US); C07K14/435 (US); A61K38/17 (EP,US);
A61K47/60 (EP,US); A61P25/00 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P43/00 (EP); C07K2319/09 (EP,US);
C07K2319/10 (EP,US); C07K2319/71 (EP,US); C07K2319/81 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/06]
Extension statesBA29.10.2015
ME29.10.2015
TitleGerman:SYNTHETISCHE TRANSKRIPTIONSFAKTOREN ZUR BEHANDLUNG VON KRANKHEITEN DURCH OPA1-HAPLOINSUFFIZIENZ[2016/06]
English:ARTIFICIAL TRANSCRIPTION FACTORS FOR THE TREATMENT OF DISEASES CAUSED BY OPA1 HAPLOINSUFFICIENCY[2016/06]
French:FACTEURS DE TRANSCRIPTION ARTIFICIELLE POUR LE TRAITEMENT D'INSUFFISANCE HAPLOÏDE[2016/06]
Entry into regional phase29.10.2015National basic fee paid 
29.10.2015Designation fee(s) paid 
29.10.2015Examination fee paid 
Examination procedure29.10.2015Examination requested  [2016/06]
28.06.2016Application deemed to be withdrawn, date of legal effect  [2016/50]
28.06.2016Loss of particular rights, legal effect: Claims
29.07.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2016/50]
29.07.2016Despatch of communication of loss of particular rights: Claims {1}
Fees paidRenewal fee
29.03.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]  - SERA ET AL, "Zinc-finger-based artificial transcription factors and their applications", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 61, no. 7-8, doi:10.1016/J.ADDR.2009.03.012, ISSN 0169-409X, (20090702), pages 513 - 526, (20090423), XP026139402 [X] 1-6,9-13 * page 515, column r, paragraph 1 - paragraph 3 * * page 517, column l, paragraph 2 - paragraph 6 * * page 519, column r, paragraph 3 * * page 522, column r, paragraph 3 - paragraph l * * table 1 * * figure 3 * [I] 7,8,14-22

DOI:   http://dx.doi.org/10.1016/j.addr.2009.03.012
 [XI]  - PAPWORTH M ET AL, "Designer zinc-finger proteins and their applications", GENE, ELSEVIER, AMSTERDAM, NL, vol. 366, no. 1, doi:10.1016/J.GENE.2005.09.011, ISSN 0378-1119, (20060117), pages 27 - 38, (20060117), XP024934269 [X] 1-6,9-13 * page 29, column l, paragraph 2 - column r, paragraph 2 * * page 31, column r, paragraph 2 - page 32, column l, paragraph 1 * * page 32, column l, paragraph 3 - column r, paragraph 1 * [I] 7,8,14-22

DOI:   http://dx.doi.org/10.1016/j.gene.2005.09.011
 [XI]  - GONZALEZ BEATRIZ ET AL, "Modular system for the construction of zinc-finger libraries and proteins", NATURE PROTOCOLS, NATURE PUBLISHING GROUP, GB, (20100401), vol. 5, no. 4, doi:10.1038/NPROT.2010.34, ISSN 1750-2799, pages 791 - 810, XP009170506 [X] 1-6,9-13 * page 792, column l, paragraph 1 - column r, paragraph 1 * * table 1 * [I] 7,8,14-22

DOI:   http://dx.doi.org/10.1038/nprot.2010.34
 [A]  - LIU PEI-QI ET AL, "Isogenic human cell lines for drug discovery: Regulation of target gene expression by engineered zinc-finger protein transcription factors", JOURNAL OF BIOMOLECULAR SCREENING, (200506), vol. 10, no. 4, ISSN 1087-0571, pages 304 - 313, XP002700123 [A] 1-22 * abstract * * page 305, column l, paragraph l * * page 306, column r, paragraph l - page 308, column l, paragraph 1 * * figures 1, 3 *

DOI:   http://dx.doi.org/10.1177/1087057104272663
 [A]  - DELETTRE CÉCILE ET AL, "Gene structure and chromosomal localization of mouse Opa1 : its exclusion from the Bst locus", BMC GENETICS, BIOMED CENTRAL, GB, (20030507), vol. 4, no. 1, doi:10.1186/1471-2156-4-8, ISSN 1471-2156, page 8, XP021014352 [A] 1-22 * page 3, column l, paragraph l - column r, paragraph 1 * * figure 3 *

DOI:   http://dx.doi.org/10.1186/1471-2156-4-8
 [A]  - HUANG NI ET AL, "Characterising and predicting haploinsufficiency in the human genome.", PLOS GENETICS OCT 2010, (201010), vol. 6, no. 10, ISSN 1553-7404, page e1001154, XP055069788 [A] 1-22 * abstract *

DOI:   http://dx.doi.org/10.1371/journal.pgen.1001154
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.